You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(02359.HK)預計第一季度營業收入增長約71.18% 扣非淨利潤增長約106.52%

格隆匯4月10日丨藥明康德(02359.HK)公佈,公司預計2022年第一季度實現營業收入約為人民幣847,441.93萬元,較2021年同期的人民幣495,047.96萬元,同比增長約71.18%。

公司預計2022年第一季度實現歸屬於公司股東的扣除非經常性損益的淨利潤約為人民幣171,414.49萬元,較上年同期的人民幣83,000.85萬元,同比增長約106.52%。

公司預計2022年第一季度實現經調整非《國際財務報吿準則》下歸屬於上市公司股東的淨利潤約為人民幣205,264.54萬元,較上年同期的人民幣110,466.80萬元,同比增長約85.82%。

公司預計2022年第一季度實現歸屬於公司股東的扣除非經常性損益的淨利潤同比增長約106.52%。公司2022年第一季度非經常性損益項目對利潤總額的影響較上年同期有所下降,主要由於:上述公司所投資標的產生的公允價值變動和投資收益影響,但另一方面,公司H股可轉股債券衍生金融工具部分的非現金賬面公允價值變動本期預計為淨收益人民幣8,279.47萬元左右,上年同期為淨損失人民幣45,109.08萬元,公允價值的變動損失較去年同期預計減少人民幣53,388.55萬元左右。

公司2022年第一季度的歸屬於上市公司股東的扣除非經常性損益的淨利潤以及經調整非《國際財務報吿準則》下歸屬於上市公司股東的淨利潤,均顯着超過收入增長速度。本公司認為經調整的財務指標有助瞭解及評估公司的業務表現及經營趨勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account